- $2.29bn
- $5.18bn
- $4.25bn
Brief: Perrigo Announces The Closing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company
Brief: Perrigo Prices $715 Mln 6.125% Senior Notes Due 2032
Brief: Perrigo Finance Unlimited Files For Offering Of $715 Mln Senior Notes
Brief: Perrigo Company PLC Files For Mixed Shelf Size Not Disclosed - SEC Filing
Brief: Perrigo-On Aug 6, Initiated Voluntary Recall At Retailer,Warehouse Level Of 16,500 Store Brand Premium Infant Formula With Iron Milk-Based Powder Cans
Perrigo recalls 16,500 cans of its infant formula
Perrigo Company PLC reports results for the quarter ended in January - Earnings Summary
Brief: Perrigo Q2 Sales USD 1,100 Million
Perrigo Company PLC expected to post earnings of 46 cents a share - Earnings Preview
Brief: Todd Penegor To Resign From Perrigo Board Effective July 31
AbbVie asks US Supreme Court to weigh protections for attorney records
Perrigo Company PLC reports results for the quarter ended in March - Earnings Summary
Brief: Perrigo Q1 Sales USD 1,100 Million
Perrigo Company PLC expected to post earnings of 23 cents a share - Earnings Preview
Brief: Perrigo Receives Binding Offer To Divest Its HRA Pharma Rare Diseases Business For Up To €275 Mln
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors
Perrigo shares jump after CVS to cover over-the-counter birth control drug - BBG
Brief: CVS To Cover Perrigo's Opill Over-The-Counter Birth Control Drug In Us - Bloomberg News
Perrigo Company PLC reports results for the quarter ended in December - Earnings Summary